Research Topics
Genomes and GenesSpecies | Vinciane ReboursSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
Smoking and the course of recurrent acute and chronic alcoholic pancreatitis: a dose-dependent relationshipVinciane Rebours
Pôle des Maladies de l Appareil Digestif, Service de Gastroentérologie Pancréatologie, Hopital Beaujon, AP HP, Clichy, France
Pancreas 41:1219-24. 2012..Smoking has been shown to affect the course of alcoholic chronic pancreatitis (ACP). However, a dose-dependent relationship between ACP course and the amount of tobacco consumption has not been studied...
Extrahepatic portal venous system thrombosis in recurrent acute and chronic alcoholic pancreatitis is caused by local inflammation and not thrombophiliaVinciane Rebours
Pôle des Maladies de l Appareil Digestif, Service de Gastroentérologie Pancréatologie, Hopital Beaujon, AP HP, Clichy, INSERM U773 CRB3, Universite Paris Diderot, Clichy, France
Am J Gastroenterol 107:1579-85. 2012..Extrahepatic portal venous system thrombosis (EPVST) occurs in 13% of patients with either recurrent acute (AP) or chronic (CP) alcoholic pancreatitis. The role of thrombophilia has never been assessed in this entity...
Familial intraductal papillary mucinous neoplasms of the pancreasVinciane Rebours
Pôle des Maladies de l Appareil Digestif, Service de Gastroentérologie Pancréatologie, Hopital Beaujon, APHP, Université Denis Diderot Paris VII, 100, boulevard du General Leclerc, 92118 Clichy, France
Dig Liver Dis 44:442-6. 2012..The prevalence of intraductal papillary mucinous neoplasms in patients with a high risk of pancreatic adenocarcinoma was estimated to be 15%. However, a familial form of intraductal papillary mucinous neoplasms was never described...
Do guidelines influence medical practice? Changes in management of acute pancreatitis 7 years after the publication of the French guidelinesVinciane Rebours
Pôle des Maladies de l Appareil Digestif, Pancreatology Unit, Beaujon Hospital, Denis Diderot Paris VII University, AP HP, Clichy, France
Eur J Gastroenterol Hepatol 24:143-8. 2012..The elaboration and publication of guidelines should help homogenizing the management of frequent diseases with high mortality and morbidity rates, such as acute pancreatitis...
Immunoglobulin G4 immunostaining of gastric, duodenal, or colonic biopsies is not helpful for the diagnosis of autoimmune pancreatitisVinciane Rebours
Department of Gastroenterology and Pancreatology, Bichat Hospital, APHP, Paris, INSERM U773 CRB3, Paris Diderot University, 92118 Clichy Cedex, France
Clin Gastroenterol Hepatol 10:91-4. 2012....
An overview of hereditary pancreatitisVinciane Rebours
Pôle des Maladies de l Appareil Digestif, Service de Gastroentérologie Pancréatologie, Hopital Beaujon, AP HP, Université Denis Diderot Paris VII, Clichy, France
Dig Liver Dis 44:8-15. 2012..7% and, 53.5%, respectively. The relative risk of cancer increases in smokers and is evaluated to 8.55. Hereditary pancreatitis diagnosis permits to propose an adapted management in expert centres...
Pathology analysis reveals that dysplastic pancreatic ductal lesions are frequent in patients with hereditary pancreatitisVinciane Rebours
Pôle des Maladies de l Appareil Digestif, Service de Gastroentérologie Pancréatologie, Hopital Beaujon, AP HP, Paris, Clichy, France
Clin Gastroenterol Hepatol 8:206-12. 2010....
Mortality rate and risk factors in patients with hereditary pancreatitis: uni- and multidimensional analysesVinciane Rebours
Pôle des Maladies de l Appareil Digestif, Service de Gastroentérologie Pancréatologie, Hopital Beaujon, AP HP, Université Denis Diderot Paris VII, 92118 Clichy, France
Am J Gastroenterol 104:2312-7. 2009..Patients with hereditary pancreatitis (HP) bear a high risk of pancreatic adenocarcinoma, but their life expectancy remains unknown. The objective of the study was to assess whether the high risk of cancer decreases survival...
Outcome of patients with type 1 or 2 autoimmune pancreatitisFrédérique Maire
Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP HP, Diderot Paris VII University, Clichy, France
Am J Gastroenterol 106:151-6. 2011....
Acute pancreatitis in patients operated on for intraductal papillary mucinous neoplasms of the pancreas: frequency, severity, and clinicopathologic correlationsAnne Laure Pelletier
Pôle des Maladies de l Appareil Digestif, Service de Gastroentérologie Pancréatologie, Hopital Beaujon, AP HP, Clichy, France
Pancreas 39:658-61. 2010..Acute pancreatitis (AP) may reveal intraductal papillary mucinous neoplasms of the pancreas (IPMN). The aims were to describe the characteristics of AP associated with IPMN and to compare patients with AP with those without AP...
Preoperative CT scan helps to predict the occurrence of severe pancreatic fistula after pancreaticoduodenectomyHadrien Tranchart
Department of Hepato Pancreato Biliary Surgery Pôle des Maladies de l Appareil Digestif PMAD, AP HP, Beaujon Hospital, Clichy, France
Ann Surg 256:139-45. 2012..To assess the influence of body fat distribution, estimated by a preoperative computed tomographic (CT) scan, on pancreatic fistula (PF) risk after pancreaticoduodenectomy (PD)...
Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive seriesVinciane Rebours
Pôle des Maladies de l Appareil Digestif, Service de Gastroentérologie Pancréatologie, Hopital Beaujon, AP HP, Université Denis Diderot Paris VII, Clichy, France
Am J Gastroenterol 103:111-9. 2008..The aims of this study were to evaluate the standardized incidence ratio (SIR) of PA in an exhaustive national series of patients with HP and to search for risk factors...
The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreasWafaa Khannoussi
Service de Pancréatologie Gastroentérologie, Pôle des Maladies de l Appareil Digestif, Hopital Beaujon, 92118 Clichy Cedex, France
Pancreatology 12:198-202. 2012..In patients (pts) with branch duct intraductal papillary mucinous neoplasms of the pancreas (BD-IPMN), the risk of malignant progression is well described at short- and mid-term. Few data beyond 5 years are available...
Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutationsCaroline Bertin
pôle biologie imagerie pathologie pharmacie, Service de Radiologie Générale, Hopital Beaujon, AP HP, université Paris VII Denis Diderot, Clichy, France
Am J Gastroenterol 107:311-7. 2012..The role of pancreas divisum (PD) as a cause of acute recurrent or chronic pancreatitis (AR/CP) is still a matter of debate...
FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-saltsCindy Neuzillet
Service de Gastroentérologie Pancréatologie, Hopital Beaujon, 100 Boulevard du General Leclerc, 92110 Clichy La Garenne, AP HP, France
World J Gastroenterol 18:4533-41. 2012..To evaluate the efficacy and safety of the FOLFIRI regimen in patients with metastatic pancreatic adenocarcinoma (PAC) after the failure of gemcitabine and platinum salts...
Recurrence after surgical resection of gastrinoma: who, when, where and why?Frédérique Maire
Department of Gastroenterology and Pancreatology, Beaujon University Hospital, AP HP, Clichy, France
Eur J Gastroenterol Hepatol 24:368-74. 2012..Surgery prolongs survival in patients with gastrinomas, but postoperative recurrences are frequent and controversies still exist about the optimal surgical procedures...
Mucinous cystic neoplasms of the pancreas: definition of preoperative imaging criteria for high-risk lesionsYann Le Baleur
Service de Pancréatologie Gastroentérologie, Pôle des Maladies de l Appareil Digestif, Hopital Beaujon, Clichy, France
Pancreatology 11:495-9. 2011..We aimed to determine if CT scan data might be useful to predict the grade of dysplasia in a series of 60 histologically proven MCN...
CFTR gene mutation in patients with apparently idiopathic pancreatitis: lack of phenotype-genotype correlationAnne Laure Pelletier
Pôle des Maladies de l Appareil Digestif, Service de Gastroentérologie Pancréatologie, Hopital Beaujon, AP HP, Clichy, France
Pancreatology 10:158-64. 2010....
Morphologic changes in branch duct intraductal papillary mucinous neoplasms of the pancreas: a midterm follow-up studyPierre Emmanuel Rautou
Pôle des Maladies de l Appareil Digestif, Service de Gastroentérologie Pancréatologie, France
Clin Gastroenterol Hepatol 6:807-14. 2008..The aim of this study was to assess time-related morphologic changes and risk of progress to malignancy in patients with BD IPMN. A prospective design was used in an academic tertiary referral center...
Endocrine pancreatic tumors in von Hippel-Lindau disease: clinical, histological, and genetic featuresOlivier Corcos
Pôle des Maladies de l Appareil Digestif, AP HP, Hopital Beaujon, Clichy, Paris, France
Pancreas 37:85-93. 2008..We aimed to assess (1) the accuracy of somatostatin receptor scintigraphy, (2) histological features with focus on malignancy and genotype-phenotype correlations, and (3) prognosis of VHL-EPT...
Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized studyFrédérique Maire
Services de Gastroentérologie Pancréatologie, Hopital Beaujon, AP HP, Clichy, France frederique maire bjn aphp fr
Neuroendocrinology 96:294-300. 2012..Systemic chemotherapy is poorly effective. Hepatic arterial embolization (HAE) and chemoembolization (HACE) have shown efficacy but have never been compared...
Overexpression of the oxygen sensors PHD-1, PHD-2, PHD-3, and FIH Is associated with tumor aggressiveness in pancreatic endocrine tumorsAnne Couvelard
Department of Pathology, University Paris 7, Clichy, France
Clin Cancer Res 14:6634-9. 2008..e., prolyl hydroxylase domain proteins (PHD)-1, PHD-2, PHD-3, and FIH in pancreatic endocrine tumors (PET)...
Gemcitabine in elderly patients with advanced pancreatic cancerOlivia Hentic
Pôle des Maladies de l Appareil Digestif, Service de Pancréatologie, Hopital Beaujon, 100 Boulevard du General Leclerc, 92110 Clichy, France
World J Gastroenterol 17:3497-502. 2011..To assess feasibility, tolerability and efficacy of gemcitabine-based chemotherapy in patients ≥ 75 years old with advanced pancreatic cancer...
Prevalence of extrapancreatic cancers in patients with histologically proven intraductal papillary mucinous neoplasms of the pancreas: a case-control studyIsabelle Baumgaertner
Pôle des Maladies de l Appareil Digestif, Service de Gastroentérologie et Pancréatologie, AP HP, Hopital Beaujon, and Denis Diderot Paris VII University, Clichy, France
Am J Gastroenterol 103:2878-82. 2008..The aim of this case-control study was to examine the association of EPC in patients with histologically proven IPMN...
Fatal bile duct necrosis: a rare complication of transcatheter arterial chemoembolization in a patient with endocrine hepatic metastasisAnne Laure Pelletier
Pôle des Maladies de l Appareil Digestif, Service de Gastroentérologie Pancréatologie, Clichy, France
Case Rep Gastroenterol 2:356-62. 2008..Even though this complication is very rare, physicians should consider this diagnosis in patients who develop chronic, marked cholestasis following a TACE procedure...
Clinical and morphological features of duodenal cystic dystrophy in heterotopic pancreasVinciane Rebours
Pôle des Maladies de l Appareil Digestif, Service de Gastroentérologie Pancréatologie, Hopital Beaujon, AP HP, Clichy, France
Am J Gastroenterol 102:871-9. 2007..The aim of this study was to determine clinical and morphological features of CDHP in a medical-surgical series of patients and to ascertain the relationship of CDHP with chronic pancreatitis (CP) in the pancreas proper...
Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patientsDaniela Speisky
Service d Anatomie Pathologique, Service de Gastroentérologie Pancréatologie, Service de Chirurgie Hépatique et Pancréatique, AP HP, Hopital Beaujon, Clichy, France
Clin Cancer Res 18:2838-49. 2012..Our aim was to characterize by molecular quantitative analysis a panel of molecules implicated in the VHL pathway and in tumor progression in the PanNET of patients with VHL...
Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors?Frédérique Maire
Pôle des Maladies de l Appareil Digestif, Service de Gastroentérologie Pancréatologie, Hopital Beaujon, Clichy, France
Surgery 145:69-75. 2009..However, 5-year recurrence occurs in 50-80% of patients in the literature. The effect of adjuvant chemotherapy (CT) on relapse-free survival (RFS) and overall survival (OS) is unknown...
[The two types of auto-immune pancreatitis]Vinciane Rebours
INSERM U773 CRB3, AP HP, Hopital Beaujon, Universite Paris Diderot Paris 7, Service de Gastroentérologie et Pancréatologie, Pôle des Maladies de l Appareil Digestif, 92118 Clichy Cedex, France
Presse Med 41:580-92. 2012..AIP diagnosis is based on association of clinical, biological and morphological features. MRI is essential to argue for AIP diagnosis. The consensual treatment is a steroid therapy (4 weeks) according to symptoms and relapses...
The expression of the hypoxia markers CA9 and CXCR4 is correlated with survival in patients with neuroendocrine tumours of the ileumLydia Deschamps
Service d Anatomie Pathologique, CRB3 INSERM U773, Hopital Beaujon, Clichy, France
Neuroendocrinology 95:214-22. 2012..Our aim was to investigate the expression of these markers in a series of patients with an ileal neuroendocrine tumour (IET) at various stages of tumorigenesis...
Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomySebastien Gaujoux
Department of Hepato pancreato biliary Surgery, Pôle des Maladies de l Appareil Digestif PMAD, Paris, France
Surgery 148:15-23. 2010..Pancreatic fistula (PF) after pancreatoduodenectomy (PD) remains a challenging problem. The only commonly accepted risk factor is the soft consistency of the pancreatic remnant...
Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumorsMaxime Palazzo
Department of Gastroenterology Pancreatology, Beaujon Hospital, Clichy, Cedex, Paris, France
Eur J Gastroenterol Hepatol 25:232-8. 2013..An antiproliferative effect of somatostatin analogs was recently demonstrated...
[Cholangiocarcinoma due to postradiation therapy cholangitis and chronic pancreatitis]Vinciane Rebours
, , , AP-HP, 100, , 92118 Clichy Cedex, France
Gastroenterol Clin Biol 29:732-4. 2005..Recurrent angiocholangitis led us to schedule a biliodigestive anastomosis. During surgery, cholangiocarcinoma was discovered. The patient died from his carcinoma some months later...
